{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:32:09Z","timestamp":1787697129106,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jpeds.2016.06.078","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T06:12:51Z","timestamp":1470463971000},"page":"90-96.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial"],"prefix":"10.1016","volume":"177","author":[{"given":"Robin H.","family":"Steinhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andjela","family":"Kusic-Pajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cornelisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gehin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Nowbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2016.06.078_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105(1 Pt 1)","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.earlhumdev.2013.09.012","article-title":"Diagnosis and treatment of pulmonary hypertension in infancy","volume":"89","author":"Steinhorn","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clp.2011.12.006","article-title":"Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents","volume":"39","author":"Porta","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0025","doi-asserted-by":"crossref","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62(25 Suppl)","author":"Ivy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-3476(97)70245-2","article-title":"Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension","volume":"130","author":"Christou","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1172\/JCI119274","article-title":"Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus","volume":"99","author":"Ivy","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0045","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2125.2009.03532.x","article-title":"Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study","volume":"68","author":"Beghetti","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0055","author":"Zisowsky"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2015.08.080","article-title":"FUTURE-2: results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion","volume":"202","author":"Berger","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2011.12.012","article-title":"Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System","volume":"885-6","author":"Ganz","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1745-6215-15-486","article-title":"Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials","volume":"15","author":"Sood","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa0803267","article-title":"Timing of elective repeat cesarean delivery at term and neonatal outcomes","volume":"360","author":"Tita","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1542\/peds.2008-0528","article-title":"Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic hernia","volume":"123","author":"Stevens","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MAT.0b013e3182904a52","article-title":"Extracorporeal Life Support Organization Registry Report 2012","volume":"59","author":"Paden","year":"2013","journal-title":"ASAIO J"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.113.3.559","article-title":"A randomized trial of early vs. standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure","volume":"113(3 Pt 1)","author":"Konduri","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0095","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/jp.2013.83","article-title":"Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term\/late preterm neonates with moderate hypoxic respiratory failure","volume":"33","author":"Konduri","year":"2013","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/jp.2009.171","article-title":"Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension","volume":"30","author":"Gonzalez","year":"2010","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003088-200443150-00003","article-title":"Clinical pharmacology of bosentan, a dual endothelin receptor antagonist","volume":"43","author":"Dingemanse","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2016.06.078_bib0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","article-title":"Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension","volume":"102","author":"Williamson","year":"2000","journal-title":"Circulation"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616305078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616305078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T21:04:37Z","timestamp":1617570277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347616305078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":21,"alternative-id":["S0022347616305078"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.06.078","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.06.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}